Development and persistence of West Nile virus-specific immunoglobulin M (IgM), IgA, and IgG in viremic blood donors.
about
Prevalence of chronic kidney disease and progression of disease over time among patients enrolled in the Houston West Nile virus cohortZika Virus Outbreak on Yap Island, Federated States of MicronesiaVirus and antibody dynamics in acute west nile virus infectionUtilization of follow-up specimens from viremic blood donors to assess the value of west nile virus immunoglobulin G avidity as an indicator of recent infectionGeographic factors contributing to a high seroprevalence of West Nile virus-specific antibodies in humans following an epidemic.Persistence of West Nile Virus-Specific Antibodies in Viremic Blood DonorsTregs control the development of symptomatic West Nile virus infection in humans and miceCase definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortiumWest Nile virus infections projected from blood donor screening data, United States, 2003Persistence of West Nile virus in the central nervous system and periphery of micePersistence of virus-specific immune responses in the central nervous system of mice after West Nile virus infection.Diagnosis and management of acute encephalitis: A practical approach.Evaluation of prolonged fatigue post-West Nile virus infection and association of fatigue with elevated antiviral and proinflammatory cytokines.Differential West Nile fever ascertainment in the United States: a multilevel analysis.Long-term clinical and neuropsychological outcomes of West Nile virus infection.West Nile virus nucleic acid persistence in whole blood months after clearance in plasma: implication for transfusion and transplantation safety.Plasma cell cerebrospinal fluid pleocytosis does not predict West Nile virus infection.West Nile virus positive blood donation and subsequent entomological investigation, Austria, 2014.West Nile virus IgM and IgG antibodies three years post- infection.Neutralizing antibodies against West Nile virus identified directly from human B cells by single-cell analysis and next generation sequencing.Persistence of detectable immunoglobulin M antibodies up to 8 years after infection with West Nile virus.Approaches for the development of rapid serological assays for surveillance and diagnosis of infections caused by zoonotic flaviviruses of the Japanese encephalitis virus serocomplex.West Nile virus infections in Greece: an update.Latest developments and challenges in the diagnosis of human West Nile virus infection.West Nile virus infection in children.Long-term neuromuscular outcomes of west nile virus infection: A clinical and electromyographic evaluation of patients with a history of infection.Estimation of dengue virus IgM persistence using regression analysis.Incidence of West Nile virus infection in the Dallas-Fort Worth metropolitan area during the 2012 epidemic.Improved reliability of serological tools for the diagnosis of West Nile fever in horses within Europe.Persistence of West Nile virus immunoglobulin M antibodies, Greece.Development time of IgG antibodies to West Nile virus.A glass microchip device for conducting serological survey of West Nile viral antibodies.Are we prepared for emerging flaviviruses in Europe? Challenges for vaccination.Surveillance and Diagnosis of West Nile Virus in the Face of Flavivirus Cross-Reactivity
P2860
Q21560788-9B0A2067-7C37-49CE-86D1-177D53712CEFQ22250881-d9588dad-42e2-8f3b-5281-cc3f0d7cb426Q24570066-1DF23760-834F-483D-B481-C37B21488FAAQ27472109-772A2306-47CE-4FDF-8EED-8BB1BE72352AQ27473031-BCAF6286-0728-434D-9619-34355B1083B7Q27481425-D7023853-CA10-4126-B3B3-BF2AB52AE6B0Q27490259-7D3F9213-6D23-4218-873A-F5725870B48AQ28533795-59CEFFAC-BF60-489E-AC21-2BE83FA28EC0Q31041026-CFDC09F6-5A55-480C-B0C3-7B2148E5E5B8Q33586206-6730BE40-C6D4-4265-85BE-BA5B3BC6DE69Q33798574-638CDC0D-AA9C-4825-B33F-638FFA51517AQ34000824-B7D26382-DD02-4BE2-8285-48A7244A418BQ34113896-BB411078-E453-4B97-9DEB-7B6945D08908Q34160088-2FA837A3-2CC3-478F-B8D1-FFF7467306BEQ34557857-0003A05E-A1B0-4733-AE5F-906AAB28D116Q34718025-C79E8CA7-DFD1-41AF-BEE2-C1D6458EF9F9Q35550751-22F2E681-00BA-4A4B-9211-C16D142018A8Q35592450-CEEB538C-FB9E-4CDB-9D22-A31E372B1CC5Q36071951-94476921-3D43-4E16-8141-76999B6132A8Q36584038-05361A2F-6DBB-47A2-A16C-25943154A7E0Q37287761-939DDC0D-85F2-4AC8-A619-6601E4D7BF78Q38008644-0343ADF6-AD59-4133-838A-BF8EB130AF7DQ38040148-5EF7CE0E-8E0F-4BF9-A6D4-D4CA23958930Q38340175-B909BE4B-7511-4071-888E-525E4B23FF99Q38577945-8EAF4ED1-7654-44A6-9E14-4CAEC4CA7A28Q38852110-10959EC2-A7DD-4435-AF3E-8F02AB1055F7Q39657666-FF96A002-5A96-447A-8AAA-80E22A735085Q40037551-40EF3D77-C1A7-4F39-8B4D-A142A2C73A05Q40038701-FE3B9B87-BF40-485F-9E15-E26B446C578BQ40315454-74CBA1FD-5D8A-476C-89F2-62A7F953A517Q40325458-E4BDDBF1-370A-485B-9F47-B86F5833B88CQ42213742-4E1161B6-FF63-4988-8BA7-6DF3C89647D7Q43047253-902AA76F-5528-4A11-B29E-A688FC35275DQ58122913-4230185D-A2E2-4181-9A74-1CC1B43A5402
P2860
Development and persistence of West Nile virus-specific immunoglobulin M (IgM), IgA, and IgG in viremic blood donors.
description
2005 nî lūn-bûn
@nan
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Development and persistence of ...... nd IgG in viremic blood donors
@nl
Development and persistence of ...... d IgG in viremic blood donors.
@ast
Development and persistence of ...... d IgG in viremic blood donors.
@en
type
label
Development and persistence of ...... nd IgG in viremic blood donors
@nl
Development and persistence of ...... d IgG in viremic blood donors.
@ast
Development and persistence of ...... d IgG in viremic blood donors.
@en
altLabel
Development and Persistence of ...... nd IgG in Viremic Blood Donors
@en
prefLabel
Development and persistence of ...... nd IgG in viremic blood donors
@nl
Development and persistence of ...... d IgG in viremic blood donors.
@ast
Development and persistence of ...... d IgG in viremic blood donors.
@en
P2093
P2860
P1476
Development and persistence of ...... d IgG in viremic blood donors.
@en
P2093
Gregory A Foster
Harry E Prince
Leslie H Tobler
Mary Lapé-Nixon
P2860
P304
P356
10.1128/JCM.43.9.4316-4320.2005
P407
P577
2005-09-01T00:00:00Z